Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

236 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized double-blind controlled trial to assess the benefits of amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill schizophrenia patients (COMBINE): methods and design.
Schmidt-Kraepelin C, Feyerabend S, Engelke C, Riesbeck M, Meisenzahl-Lechner E, Gaebel W, Verde PE, Kolbe H, Correll CU, Leucht S, Heres S, Kluge M, Makiol C, Neff A, Lange C, Englisch S, Zink M, Langguth B, Poeppl T, Reske D, Gouzoulis-Mayfrank E, Gründer G, Hasan A, Brockhaus-Dumke A, Jäger M, Baumgärtner J, Wobrock T, Cordes J. Schmidt-Kraepelin C, et al. Among authors: cordes j. Eur Arch Psychiatry Clin Neurosci. 2020 Feb;270(1):83-94. doi: 10.1007/s00406-019-01063-4. Epub 2019 Sep 5. Eur Arch Psychiatry Clin Neurosci. 2020. PMID: 31486890
Repetitive transcranial magnetic stimulation for the treatment of negative symptoms in residual schizophrenia: rationale and design of a sham-controlled, randomized multicenter study.
Cordes J, Falkai P, Guse B, Hasan A, Schneider-Axmann T, Arends M, Winterer G, Wölwer W, Ben Sliman E, Ramacher M, Schmidt-Kraepelin C, Ohmann C, Langguth B, Landgrebe M, Eichhammer P, Frank E, Burger J, Hajak G, Rietschel M, Wobrock T. Cordes J, et al. Eur Arch Psychiatry Clin Neurosci. 2009 Nov;259 Suppl 2:S189-97. doi: 10.1007/s00406-009-0060-y. Eur Arch Psychiatry Clin Neurosci. 2009. PMID: 19876678 Clinical Trial.
The tolerability of rTMS treatment in schizophrenia with respect to cognitive function.
Mittrach M, Thünker J, Winterer G, Agelink MW, Regenbrecht G, Arends M, Mobascher A, Kim SJ, Wölwer W, Brinkmeyer J, Gaebel W, Cordes J. Mittrach M, et al. Among authors: cordes j. Pharmacopsychiatry. 2010 May;43(3):110-7. doi: 10.1055/s-0029-1242824. Epub 2010 Feb 2. Pharmacopsychiatry. 2010. PMID: 20127616 Clinical Trial.
Relapse prevention in schizophrenia and schizoaffective disorder with risperidone long-acting injectable vs quetiapine: results of a long-term, open-label, randomized clinical trial.
Gaebel W, Schreiner A, Bergmans P, de Arce R, Rouillon F, Cordes J, Eriksson L, Smeraldi E. Gaebel W, et al. Among authors: cordes j. Neuropsychopharmacology. 2010 Nov;35(12):2367-77. doi: 10.1038/npp.2010.111. Epub 2010 Aug 4. Neuropsychopharmacology. 2010. PMID: 20686456 Free PMC article. Clinical Trial.
Can an early weight management program (WMP) prevent olanzapine (OLZ)-induced disturbances in body weight, blood glucose and lipid metabolism? Twenty-four- and 48-week results from a 6-month randomized trial.
Cordes J, Thünker J, Regenbrecht G, Zielasek J, Correll CU, Schmidt-Kraepelin C, Lange-Asschenfeldt C, Agelink MW, Kahl KG, Gaebel W, Klimke A, Hauner H. Cordes J, et al. World J Biol Psychiatry. 2014 Apr;15(3):229-41. doi: 10.3109/15622975.2011.592546. Epub 2011 Jul 11. World J Biol Psychiatry. 2014. PMID: 21745127 Clinical Trial.
Rationale and baseline characteristics of PREVENT: a second-generation intervention trial in subjects at-risk (prodromal) of developing first-episode psychosis evaluating cognitive behavior therapy, aripiprazole, and placebo for the prevention of psychosis.
Bechdolf A, Müller H, Stützer H, Wagner M, Maier W, Lautenschlager M, Heinz A, de Millas W, Janssen B, Gaebel W, Michel TM, Schneider F, Lambert M, Naber D, Brüne M, Krüger-Özgürdal S, Wobrock T, Riedel M, Klosterkötter J; PREVENT study group. Bechdolf A, et al. Schizophr Bull. 2011 Sep;37 Suppl 2(Suppl 2):S111-21. doi: 10.1093/schbul/sbr083. Schizophr Bull. 2011. PMID: 21860040 Free PMC article. Clinical Trial.
236 results